Skip to main content
Sign In
HHS Logo
U.S. Department of Health & Human Services
Search Icon
Menu Icon
 
 

Enabling Innovations and Technology (EIT) Office


Industrial Base Management and Supply Chain (IBMSC)
Widescreen picture, scientist configures control panel - stock photo


What is the EIT Office?

The EIT office is a component of IBMSC that significantly contributes to strengthening U.S. manufacturing capabilities and ensuring resilient supply chain for public health emergencies. EIT leads efforts to enable, engage and enhance domestic supplies of critical drug substances and drug products and to improve access to these supplies.

EIT in Action

  • Distributed and Agile Manufacturing. EIT is developing a rapidly adaptable, scalable, and distributed network of medicine-producing systems comprised of notes, including drug substance and drug product manufacturing nodes, that complement point-of-care sterile/non-sterile medicine compounding nodes.
  • On-Shoring of Drug Stubstance and Drug Product Production: EIT is onshoring the production of essential medicines to the U.S.  This will generate domestic self-sufficiency for manufacturing critical, generic API's and finished drug products to prevent future shortages with semi-continuous processing and manufacturing.
  • Distributed Saline Manufacturing: EIT is addressing the need t improve the U.S. pharmaceutical base through scalable and distributed manufacturing and production of saline IV fluid therapies with potential to expand into other fluids or medications for infusion therapies or dialysis, at the point of need.


Why is the CME Office Important?

The EIT Office advances the development, deployment, and on-shoring of manufacturing capacities for Key Starting Materials, Drug Substances and Drug Products that enables agile and distributed cGMP compliant production of pharmaceuticals and supportive care fluids.  These manufacturing capacities will help strengthen supply chain resilience, grow the bioeconomy, and deploy increasingly agile, renewable and sustainable pharmaceutical resources capable of immediately responding to surges in demand caused by public health emergencies. 














IBMSC Right-Nav

IBMSC